Literature DB >> 8353054

Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.

I Diez-Itza1, A M Merino, J Tolivia, F Vizoso, L M Sánchez, C López-Otín.   

Abstract

We have examined by immunohistochemistry the ability of breast carcinomas to produce pepsinogen C, an aspartyl proteinase usually involved in the digestion of proteins in the stomach. A total of 113 out of 245 breast tumours (46%) were positive for pepsinogen C immunostaining. There was a significant association between pepsinogen C and oestrogen receptors with proteinase levels higher (HSCORE) in oestrogen receptor positive tumours than in oestrogen receptor negative. There was also a significant association between pepsinogen C and histological grade, pepsinogen C levels being higher in well and moderately differentiated breast carcinomas than in poorly differentiated tumours. On the basis of these results, we suggest that pepsinogen C may be useful as a marker of good prognosis in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353054      PMCID: PMC1968393          DOI: 10.1038/bjc.1993.399

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  A new technique for differential and simultaneous staining of nerve cells and fibers.

Authors:  J Tolivia; D Tolivia
Journal:  J Neurosci Methods       Date:  1985-05       Impact factor: 2.390

2.  Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas.

Authors:  A P Sappino; N Busso; D Belin; J D Vassalli
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

3.  Production of antisera with small doses of immunogen: multiple intradermal injections.

Authors:  J L Vaitukaitis
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Lysosomal cathepsin B: correlation with metastatic potential.

Authors:  B F Sloane; J R Dunn; K V Honn
Journal:  Science       Date:  1981-06-05       Impact factor: 47.728

Review 5.  Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?

Authors:  H Rochefort; F Capony; M Garcia; V Cavaillès; G Freiss; M Chambon; M Morisset; F Vignon
Journal:  J Cell Biochem       Date:  1987-09       Impact factor: 4.429

Review 6.  Gene products which play a role in cancer invasion and metastasis.

Authors:  L A Liotta
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

7.  Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.

Authors:  K S McCarty; E Szabo; J L Flowers; E B Cox; G S Leight; L Miller; J Konrath; J T Soper; D A Budwit; W T Creasman
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart.

Authors:  B Foltmann; A L Jensen
Journal:  Eur J Biochem       Date:  1982-11

9.  Tissue-type plasminogen activator, a new prognostic marker in breast cancer.

Authors:  M J Duffy; P O'Grady; D Devaney; L O'Siorain; J J Fennelly; H R Lijnen
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  9 in total

1.  Prenatal antiepileptic exposure associates with neonatal DNA methylation differences.

Authors:  Alicia K Smith; Karen N Conneely; D Jeffrey Newport; Varun Kilaru; James W Schroeder; Page B Pennell; Bettina T Knight; Joseph C Cubells; Zachary N Stowe; Patricia A Brennan
Journal:  Epigenetics       Date:  2012-05-01       Impact factor: 4.528

2.  Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression.

Authors:  Yasuyo Tani; Yoshimitsu Akiyama; Hiroshi Fukamachi; Kazuyoshi Yanagihara; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-28       Impact factor: 4.553

3.  Prostate specific antigen--a new constituent of breast cyst fluid.

Authors:  E P Diamandis; H Yu; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Pepsinogen C proteolytic processing of surfactant protein B.

Authors:  Kristin D Gerson; Cherie D Foster; Peggy Zhang; Zhenguo Zhang; Michael M Rosenblatt; Susan H Guttentag
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

5.  Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.

Authors:  Y Miyasaka; N Enomoto; K Nagayama; N Izumi; F Marumo; M Watanabe; C Sato
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

Review 6.  Pepsinogen C expression, regulation and its relationship with cancer.

Authors:  Shixuan Shen; Jingyi Jiang; Yuan Yuan
Journal:  Cancer Cell Int       Date:  2017-05-23       Impact factor: 5.722

7.  Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.

Authors:  Elizabeth M Azzato; Kristy E Driver; Fabienne Lesueur; Mitul Shah; David Greenberg; Douglas F Easton; Andrew E Teschendorff; Carlos Caldas; Neil E Caporaso; Paul D P Pharoah
Journal:  Breast Cancer Res       Date:  2008-05-28       Impact factor: 6.466

8.  Differential gene-expression profiles associated with gastric adenoma.

Authors:  H Takenawa; M Kurosaki; N Enomoto; Y Miyasaka; N Kanazawa; N Sakamoto; T Ikeda; N Izumi; C Sato; M Watanabe
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

9.  Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.

Authors:  Emilio Ugalde-Morales; Felix Grassmann; Keith Humphreys; Jingmei Li; Mikael Eriksson; Nicholas P Tobin; Åke Borg; Johan Vallon-Christersson; Per Hall; Kamila Czene
Journal:  Int J Cancer       Date:  2020-09-05       Impact factor: 7.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.